Search results
Results from the WOW.Com Content Network
AMAG Pharmaceuticals (AMAG) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
For premium support please call: 800-290-4726 more ways to reach us
What's next for the stock? We take a look at earnings estimates for some clues. AMAG Pharmaceuticals (AMAG) Down 8.9% Since Last Earnings Report: Can It Rebound?
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
Image source: Getty Images. The most prudent course of action for investors. To summarize, the consensus estimate says the PCE inflation reading for October will clock in at 2.1%.
For premium support please call: 800-290-4726 more ways to reach us